Navigation Links
Bend Research Presents Drug Delivery Advancements at Controlled Release Society Annual Meeting

Bend, Oregon (PRWEB) July 16, 2013

Bend Research Inc., a leading independent scientific development and manufacturing company, today announced a full schedule of events at the 40th Annual Meeting & Exposition of the Controlled Release Society (CRS), being held July 21–24 at the Hawaii Convention Center in Honolulu.

“We are looking forward to returning to the CRS meeting this year to share our recent advancements in drug delivery,” said David Lyon, Senior Vice President at Bend Research. “We also are eager to meet with clients and peers to discuss the latest developments in topics ranging from oral solubilization technology to multiparticulate oral drug delivery systems.”

David Lyon, Ph.D., will be moderating the scientific session titled, “Solubilization Technology – A Key Enabler for the Delivery of Poorly Soluble Drugs,” July 22 at 10:30 a.m.–12:00 p.m. HAST.

In addition, Brett Caldwell, Ph.D., will participate in the following presentations and talks during the CRS meeting:

  • Presentation during the soapbox session titled, “Enabling Pharmacokinetic Control of Solubilized Forms,” July 21 at 1:50–1:55 p.m. HAST.
  • Presentation of a poster (board 501, session 1) titled, “The Utility of Modified-Release, Osmotic Tablet Technology in the Early Stages of Pharmaceutical Development,” July 22 from 9:30-10:30 a.m. HAST.
  • Discussion in the roundtable session titled, “Multiparticulate Oral Drug Delivery Systems for Fixed Dose Combinations,” July 23 at 4:00–5:30 p.m. HAST. This will be an overview of the multiparticulate opportunities for fixed dose combinations and will include case studies to illustrate the challenges and best practices.

Attendees can visit Booth #303 to learn more about Bend Research and its services and technologies.

Contact: To schedule a meeting with Bend Research experts or for any other press inquiry, please contact Phoenix Barringer at phoenix.barringer(at)bendresearch(dot)com or 541-382-4100.

About Bend Research
For more than 35 years, Bend Research Inc. has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company’s ability to develop, advance, and commercialize pharmaceutical technologies, which grow from a solid base of scientific and engineering fundamental understanding.

Bend Research Inc. provides several capabilities, including formulation and dosage-form support, assists in process development and optimization, manufactures clinical trial quantities of drug candidates in its cGMP facilities, and advances promising drug candidates from conception through commercialization. The company is a leader in novel formulations, including spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies. With more than 285 employees, Bend Research Inc. is based in six state-of-the-art facilities in Bend, Oregon, USA.

Follow Bend Research on LinkedIn at For more information, visit


Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. BioInformatics LLC—New Report Finds High Degree of Satisfaction With Instrumentation Performance Among Researchers
2. Sarah Cannon Research Institute Implements Virtify CTRR
3. York Nanocentre researchers image individual atoms in a living catalytic reaction
4. Funding Tomorrow's Biomedical Research: California Healthcare Institute Hosts Pipeline for Life, July 15
5. Comprehensive Topical Reports by Transparency Market Research Now Available at
6. Medrio, a Leading EDC Provider for Clinical Research, Announces Its Latest Version, 8.1 with iPad Support, is Available Without Charge for Academic Researchers
7. BioInformatics, LLC New Market Research Report – Life Science Instruments: Brand Performance
8. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
9. New Research from SRI International Points to Biomarker that Could Track Huntingtons Disease Progression
10. Allegheny General Hospital Neurosurgeon Receives NIH Grant for Brain Aneurysm Research
11. Elsevier Promotes Local Research Efforts in Pakistan Through "Quiz for Science"
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016 Epic ... sensitively detects cancers susceptible to PARP inhibitors by ... tumor cells (CTCs). The new test has already ... therapeutics in multiple cancer types. Over ... DNA damage response pathways, including PARP, ATM, ATR, ...
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young Investigator ... Members of the Class of 2016 were selected from a pool of 128 ... About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
Breaking Biology Technology:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:4/28/2016)... and BANGALORE, India , April ... EdgeVerve Systems, a product subsidiary of Infosys (NYSE: ... today announced a global partnership that will provide ... to use mobile banking and payment services.      ... a key innovation area for financial services, but it also ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):